Skip to main content
. 2016 Apr 18;8(16):25885–25896. doi: 10.18632/oncotarget.8834

Table 1. Relationship of BCL-9 expression and clinicopathological parameters in colorectal cancer patients (n = 284).

Variable n BCL-9 expression p-value
+ ++
Gender 0.894*
 Male 166 98 48 20
 Female 118 68 37 13
Age (yr) 0.132*
 < 65 161 101 42 18
 ≥ 65 123 65 43 15
Invasion depth 0.000**
 T1 3 3 0 0
 T2 82 66 13 3
 T3 195 97 71 27
 T4 4 0 1 3
Lymph node metastasis 0.000**
 N0 205 132 55 18
 N1 71 34 24 13
 N2 8 0 6 2
Distant metastasis 0.191*
 M0 282 166 83 33
 M1 2 0 2 0
AJCC TNM stage 0.000**
 I 72 62 7 3
 II 133 70 47 16
 III 77 34 29 14
 IV 2 0 2 0
Tumor pathological type 0.527**
 Adenocarcinoma 258 148 80 30
 Mucinous adenocarcinoma 15 10 3 2
 Papillary adenocarcinoma 9 7 1 1
 Undifferentiated carcinoma 1 0 1 0
 Signet-ring cell carcinoma 1 0 0 1

* using Mann-Whitney U test;

** using Kruskal-Wallis test.